Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-Related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy.
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Cancer metastases; Prostate cancer
- Focus Therapeutic Use
- Sponsors Novartis
- 28 Nov 2011 Location (Venezuela) and actual patient number 38 added as reported by ClinicalTrials.gov.
- 20 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Oct 2009 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.